Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...

We are a multidisciplinary research group comprising of neuroscientists across the Faculties of Science and Medicine at the University of Sheffield. We are also a member of both the Neuroscience ...

However, high cost of neurovascular devices restricts the growth of the U.S. neurovascular devices market. Conversely, surge in demand for minimally invasive procedures in the U.S provides lucrative ...

The neurointerventional device market is expected to witness significant growth in the coming decade, with projections indicating a rise from USD 2,824.2 million in 2025 to USD 4,477.6 million by 2035 ...